218 related articles for article (PubMed ID: 18214858)
1. Site-specific analysis of N-glycans on haptoglobin in sera of patients with pancreatic cancer: a novel approach for the development of tumor markers.
Nakano M; Nakagawa T; Ito T; Kitada T; Hijioka T; Kasahara A; Tajiri M; Wada Y; Taniguchi N; Miyoshi E
Int J Cancer; 2008 May; 122(10):2301-9. PubMed ID: 18214858
[TBL] [Abstract][Full Text] [Related]
2. Fucosylated haptoglobin is a novel marker for pancreatic cancer: detailed analyses of oligosaccharide structures.
Miyoshi E; Nakano M
Proteomics; 2008 Aug; 8(16):3257-62. PubMed ID: 18646007
[TBL] [Abstract][Full Text] [Related]
3. Site-specific and linkage analyses of fucosylated N-glycans on haptoglobin in sera of patients with various types of cancer: possible implication for the differential diagnosis of cancer.
Takahashi S; Sugiyama T; Shimomura M; Kamada Y; Fujita K; Nonomura N; Miyoshi E; Nakano M
Glycoconj J; 2016 Jun; 33(3):471-82. PubMed ID: 26869352
[TBL] [Abstract][Full Text] [Related]
4. Glycosylation status of haptoglobin in sera of patients with prostate cancer vs. benign prostate disease or normal subjects.
Fujimura T; Shinohara Y; Tissot B; Pang PC; Kurogochi M; Saito S; Arai Y; Sadilek M; Murayama K; Dell A; Nishimura S; Hakomori SI
Int J Cancer; 2008 Jan; 122(1):39-49. PubMed ID: 17803183
[TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of site-specific N-glycans on sera haptoglobin β chain in liver diseases.
Zhang S; Jiang K; Sun C; Lu H; Liu Y
Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):1021-9. PubMed ID: 24103369
[TBL] [Abstract][Full Text] [Related]
6. ESI-LC-MS Method for Haptoglobin Fucosylation Analysis in Hepatocellular Carcinoma and Liver Cirrhosis.
Zhang Y; Zhu J; Yin H; Marrero J; Zhang XX; Lubman DM
J Proteome Res; 2015 Dec; 14(12):5388-95. PubMed ID: 26503433
[TBL] [Abstract][Full Text] [Related]
7. Mass spectrometric assay for analysis of haptoglobin fucosylation in pancreatic cancer.
Lin Z; Simeone DM; Anderson MA; Brand RE; Xie X; Shedden KA; Ruffin MT; Lubman DM
J Proteome Res; 2011 May; 10(5):2602-11. PubMed ID: 21417406
[TBL] [Abstract][Full Text] [Related]
8. Clinical application of a lectin-antibody ELISA to measure fucosylated haptoglobin in sera of patients with pancreatic cancer.
Matsumoto H; Shinzaki S; Narisada M; Kawamoto S; Kuwamoto K; Moriwaki K; Kanke F; Satomura S; Kumada T; Miyoshi E
Clin Chem Lab Med; 2010 Apr; 48(4):505-12. PubMed ID: 20128732
[TBL] [Abstract][Full Text] [Related]
9. Verification of the effectiveness of fucosylated haptoglobin as a pancreatic cancer marker in clinical diagnosis.
Kuwatani M; Kawakami H; Kubota Y; Kawakubo K; Ito YM; Togo S; Ikeda T; Kusama K; Kobayashi Y; Murata T; Sakamoto N
Pancreatology; 2019 Jun; 19(4):569-577. PubMed ID: 31031206
[TBL] [Abstract][Full Text] [Related]
10. Identification of fucosylated haptoglobin as a novel tumor marker for pancreatic cancer and its possible application for a clinical diagnostic test.
Miyoshi E; Shinzaki S; Moriwaki K; Matsumoto H
Methods Enzymol; 2010; 478():153-64. PubMed ID: 20816478
[TBL] [Abstract][Full Text] [Related]
11. Glycosylation of site-specific glycans of alpha1-acid glycoprotein and alterations in acute and chronic inflammation.
Higai K; Aoki Y; Azuma Y; Matsumoto K
Biochim Biophys Acta; 2005 Aug; 1725(1):128-35. PubMed ID: 15863355
[TBL] [Abstract][Full Text] [Related]
12. Establishment of a novel lectin-antibody ELISA system to determine core-fucosylated haptoglobin.
Shimomura M; Nakayama K; Azuma K; Terao N; Nishino K; Takamatsu S; Nakano M; Takahashi S; Kobayashi Y; Murata K; Kamada Y; Miyoshi E
Clin Chim Acta; 2015 Jun; 446():30-6. PubMed ID: 25861849
[TBL] [Abstract][Full Text] [Related]
13. α1-3/4 fucosylation at Asn 241 of β-haptoglobin is a novel marker for colon cancer: a combinatorial approach for development of glycan biomarkers.
Park SY; Lee SH; Kawasaki N; Itoh S; Kang K; Hee Ryu S; Hashii N; Kim JM; Kim JY; Hoe Kim J
Int J Cancer; 2012 May; 130(10):2366-76. PubMed ID: 21780104
[TBL] [Abstract][Full Text] [Related]
14. Analysis of haptoglobin N-glycome alterations in inflammatory and malignant lung diseases by capillary electrophoresis.
Váradi C; Mittermayr S; Szekrényes Á; Kádas J; Takacs L; Kurucz I; Guttman A
Electrophoresis; 2013 Aug; 34(16):2287-94. PubMed ID: 23580236
[TBL] [Abstract][Full Text] [Related]
15. Quantitative liquid chromatography-mass spectrometry-multiple reaction monitoring (LC-MS-MRM) analysis of site-specific glycoforms of haptoglobin in liver disease.
Sanda M; Pompach P; Brnakova Z; Wu J; Makambi K; Goldman R
Mol Cell Proteomics; 2013 May; 12(5):1294-305. PubMed ID: 23389048
[TBL] [Abstract][Full Text] [Related]
16. Glycomic profiling of targeted serum haptoglobin for gastric cancer using nano LC/MS and LC/MS/MS.
Lee SH; Jeong S; Lee J; Yeo IS; Oh MJ; Kim U; Kim S; Kim SH; Park SY; Kim JH; Park SH; Kim JH; An HJ
Mol Biosyst; 2016 Nov; 12(12):3611-3621. PubMed ID: 27722599
[TBL] [Abstract][Full Text] [Related]
17. LC-MS/MS isomeric profiling of permethylated N-glycans derived from serum haptoglobin of hepatocellular carcinoma (HCC) and cirrhotic patients.
Huang Y; Zhou S; Zhu J; Lubman DM; Mechref Y
Electrophoresis; 2017 Sep; 38(17):2160-2167. PubMed ID: 28543513
[TBL] [Abstract][Full Text] [Related]
18. Novel glycan biomarkers for the detection of lung cancer.
Arnold JN; Saldova R; Galligan MC; Murphy TB; Mimura-Kimura Y; Telford JE; Godwin AK; Rudd PM
J Proteome Res; 2011 Apr; 10(4):1755-64. PubMed ID: 21214223
[TBL] [Abstract][Full Text] [Related]
19. Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation.
Okuyama N; Ide Y; Nakano M; Nakagawa T; Yamanaka K; Moriwaki K; Murata K; Ohigashi H; Yokoyama S; Eguchi H; Ishikawa O; Ito T; Kato M; Kasahara A; Kawano S; Gu J; Taniguchi N; Miyoshi E
Int J Cancer; 2006 Jun; 118(11):2803-8. PubMed ID: 16385567
[TBL] [Abstract][Full Text] [Related]
20. N-glycosylation status of beta-haptoglobin in sera of patients with colon cancer, chronic inflammatory diseases and normal subjects.
Park SY; Yoon SJ; Jeong YT; Kim JM; Kim JY; Bernert B; Ullman T; Itzkowitz SH; Kim JH; Hakomori SI
Int J Cancer; 2010 Jan; 126(1):142-55. PubMed ID: 19551866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
